A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
Cellular Oncology · 2025
DOI: 10.1007/s13402-024-00960-8 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cellular Oncology, 2025. Verfasst von Jessica Kalla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Precision Medicine, Organoids, Neoplasms, Cell Culture Techniques. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 295 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Medical University of Vienna.
Abstract (Originalsprache)
Cancer is a highly heterogeneous disease, and thus treatment responses vary greatly between patients. To improve therapy efficacy and outcome for cancer patients, more representative and patient-specific preclinical models are needed. Organoids and tumoroids are 3D cell culture models that typically retain the genetic and epigenetic characteristics, as well as the morphology, of their tissue of origin. Thus, they can be used to understand the underlying mechanisms of cancer initiation, progression, and metastasis in a more physiological setting. Additionally, co-culture methods of tumoroids and cancer-associated cells can help to understand the interplay between a tumor and its tumor microenvironment. In recent years, tumoroids have already helped to refine treatments and to identify new targets for cancer therapy. Advanced culturing systems such as chip-based fluidic devices and bioprinting methods in combination with tumoroids have been used for high-throughput applications for personalized medicine. Even though organoid and tumoroid models are complex in vitro systems, validation of results in vivo is still the common practice. Here, we describe how both animal- and human-derived tumoroids have helped to identify novel vulnerabilities for cancer treatment in recent years, and how they are currently used for precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Medical University of Vienna, Vienna, Austria.
- Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
- Department of Pathology, Medical University of Vienna, Vienna, Austria. gerda.egger@meduniwien.ac.at.
- Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria. gerda.egger@meduniwien.ac.at.
- Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. gerda.egger@meduniwien.ac.at.
Förderung
- Austrian Science Fund FWF
- Medical University of Vienna
Zitieren
APA
Kalla, J., Pfneissl, J., Mair, T., Tran, L., & Egger, G. (2025). A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine. Cellular Oncology. https://doi.org/10.1007/s13402-024-00960-8
Vancouver
Kalla J, Pfneissl J, Mair T, Tran L, Egger G. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine. Cellular Oncology. 2025. doi:10.1007/s13402-024-00960-8
BibTeX
@article{Kalla2025,
author = {Kalla, Jessica and Pfneissl, Janette and Mair, Theresia and Tran, Loan and Egger, Gerda},
title = {A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-024-00960-8}
}
EUVIMED